|
AP3M1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.47889997417872E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.66089999987085E-07 |
| Normal-vs-Stage2 |
2.11549999999949E-05 |
| Normal-vs-Stage3 |
4.7225001686968E-10 |
| Normal-vs-Stage4 |
2.93049995381267E-09 |
| Stage1-vs-Stage2 |
5.868600E-01 |
| Stage1-vs-Stage3 |
3.619800E-02 |
| Stage1-vs-Stage4 |
3.176300E-02 |
| Stage2-vs-Stage3 |
3.441800E-01 |
| Stage2-vs-Stage4 |
1.928360E-01 |
| Stage3-vs-Stage4 |
5.669800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.31880009322106E-10 |
| Normal-vs-AfricanAmerican |
3.899500E-03 |
| Normal-vs-Asian |
3.05150000001753E-06 |
| Caucasian-vs-AfricanAmerican |
2.647600E-01 |
| Caucasian-vs-Asian |
8.461800E-01 |
| AfricanAmerican-vs-Asian |
3.749000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.59100005287161E-09 |
| Normal-vs-Female |
2.32000000321975E-08 |
| Male-vs-Female |
2.354200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.12109999999655E-05 |
| Normal-vs-Age(41-60Yrs) |
9.75679981252142E-10 |
| Normal-vs-Age(61-80Yrs) |
4.45710002239252E-09 |
| Normal-vs-Age(81-100Yrs) |
2.159000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.295800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.109600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.689600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.296400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.287800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.836200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.647700E-02 |
| Classical-VS-Follicular |
7.970800E-01 |
| Classical-VS-Other |
1.250570E-01 |
| Classical-VS-Normal |
3.52340000508988E-08 |
| Tall-VS-Follicular |
9.370400E-02 |
| Tall-VS-Other |
5.701800E-01 |
| Tall-VS-Normal |
7.70629999813366E-08 |
| Follicular-VS-Other |
2.634600E-01 |
| Follicular-VS-Normal |
4.12690000000104E-05 |
| Other-VS-Normal |
5.170400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.2067000005066E-08 |
| Normal-vs-N1 |
3.96209998143604E-09 |
| N0-vs-N1 |
1.228240E-01 |
|
|
